InvestorsHub Logo

rocalinda

04/24/17 5:00 PM

#102767 RE: UnderVerse #102760

Thanks for posting.

This just more confirmation that funding is not an issue. Dr. M. wants to be sure that PH-3 will succeed by knowing what type of patients will react most positively to the drug. Not, ethical to patients or best for shareholders to proceed with uncertainty.

I believe patience will be rewarded here.

GLTA